# OnCo record bgb-16673 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bgb-16673/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bgb-16673" ;
  schema:name "BGB-16673"@en ;
  schema:description "Instead of blocking BTK, this pill destroys it, so it works even when the enzyme has mutated to escape every inhibitor."@en ;
  schema:url <https://onco.cc/drugs/bgb-16673/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://ashpublications.org/blood/article/146/Supplement%201/5691/550156/CaDAnCe-304-a-phase-3-open-label-randomized-study> ;
  onco:status "phase-3" ;
  onco:modality "Small-molecule BTK degrader (CDAC)" ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/btk/> ;
  onco:companies <https://onco.cc/companies/beone/> ;
  onco:trials <https://onco.cc/trials/cadance-304/>, <https://onco.cc/trials/nct05006716/>, <https://onco.cc/trials/nct05294731/>, <https://onco.cc/trials/nct06970743/> .